In the world of investing, dividends can be a powerful tool for wealth accumulation. Today, we're diving into three dividend stocks that could be worth your attention this June. But before we begin, let's unpack why dividends matter and how they can impact your investment strategy.
The Power of Dividends:
Dividends are a key indicator of a company's financial health and stability. As the data shows, companies that consistently pay dividends, especially those with growing dividend yields, tend to outperform their peers over time. This is a powerful insight for investors seeking long-term wealth accumulation. The table provided offers a stark reminder: dividend growers and initiators have averaged an impressive 10.22% annual total return from 1973 to 2025, significantly outpacing the equal-weighted S&P 500 index's 7.74% return.
Now, let's explore three stocks that could be worth buying hand over fist this June.
Pfizer: A Pharmaceutical Giant with a Generous Yield
Pfizer, a pharmaceutical behemoth, offers an enticing dividend yield of 6.7% as of my last knowledge update. This high yield is partly due to the stock's recent performance, with an average annual loss of about 7% over the past three years. However, it's important to note that Pfizer's stock has rebounded, gaining 17% in the past year as of June 4. This rebound is a positive sign, indicating potential for future growth.
One of the key challenges for Pfizer, and indeed for the entire pharmaceutical industry, is the expiration of patent protection for some of its top-selling drugs. To address this, Pfizer is actively developing a pipeline of promising new drugs and acquiring them from other companies. This strategy is a common approach in the industry to ensure a steady stream of revenue and maintain competitiveness.
From my perspective, Pfizer's shares appear undervalued. With a forward P/E ratio of 9.0, significantly lower than its five-year average of 9.7, it presents an attractive opportunity for investors. This undervaluation could be a result of market concerns about its patent expiration issues, creating a buying opportunity for those who believe in Pfizer's long-term prospects.
United Parcel Service (UPS): Beyond Amazon
United Parcel Service, or UPS, is another stock with an impressive dividend yield, currently at 7.7%. Like Pfizer, UPS has faced some challenges, with average annual losses of 8.6% over the past three years. However, there are several reasons to be optimistic about UPS's future.
One controversial move by UPS was its decision to reduce deliveries for Amazon.com, a major client. While this decision has caused concern among some investors, others see it as a strategic move to focus on higher-margin customers, such as small and medium-sized businesses and the healthcare sector. This shift in focus could potentially improve UPS's profitability and long-term viability.
UPS's first-quarter report provides some encouraging signs. Domestic revenue decreased by 2.3%, but revenue per package grew by a healthy 6.5%. Internationally, revenue rose by 3.8%, with revenue per package increasing by an impressive 12.1%. These figures suggest that UPS is adapting well to changing market dynamics and focusing on more profitable segments.
UPS's shares are reasonably valued, with a forward P/E ratio of 14, slightly below its five-year average of 15. This suggests that the market is pricing in some of the challenges UPS is facing, creating an opportunity for long-term investors who believe in UPS's ability to adapt and thrive.
Schwab U.S. Dividend Equity ETF: A Diversified Approach
My final suggestion is not a stock but an exchange-traded fund (ETF) called the Schwab U.S. Dividend Equity ETF (SCHD). This ETF offers a diversified approach to dividend investing, with a yield of 3.25% as of my last knowledge update. It invests across approximately 100 dividend-paying stocks, including well-known companies like Qualcomm, Texas Instruments, and UnitedHealth Group.
The ETF's performance has been impressive, with a nearly 20% gain year-to-date as of June 4. This growth, combined with its solid dividend yield, makes it an attractive option for investors seeking both income and growth. Additionally, the ETF's diversification across multiple sectors and companies reduces risk, providing a more stable investment option compared to individual dividend stocks.
Conclusion
In conclusion, these three dividend stocks and the ETF offer a compelling opportunity for investors seeking income and long-term growth. While each has its challenges, they also present unique strengths and potential for future success. As with any investment, it's essential to conduct thorough research and consider your own risk tolerance and investment goals. Remember, investing is a marathon, not a sprint, and a well-diversified portfolio can be a powerful tool for achieving your financial objectives.
